Sinovac - Asia Tech Wire

Sinovac

2024.06.05

07:34

Sinovac plans to invest $100 million in Brazil starting this year

Asia Tech Wire (June 5) -- Chinese pharmaceutical company Sinovac Biotech Ltd. plans to invest $100 million in Brazil starting this year.

2021.12.15

08:39

HKU study shows 2-dose course of Pfizer, Sinovac vax inadequate against Omicron

Asian Tech Press (Dec 15)-- Two doses of the Pfizer-BioNTech or Sinovac COVID-19 vaccine are inadequate against the Omicron variant, and a third dose is recommended as soon as possible, according to research released Tuesday by the University of Hong Kong (HKU).

2021.11.17

11:25

Malaysia approves Sinovac, AstraZeneca's COVID-19 vaccines as booster shots

Asian Tech Press (Nov 17) -- Malaysia has conditionally approved Sinovac and AstraZeneca's COVID-19 vaccines as booster shots.

2021.11.09

07:14

UK adds Sinovac, Sinopharm Beijing, Covaxin vaccines to approved travel list

Asian Tech Press (Nov 09) -- The UK government has announced that it will recognize the World Health Organization's (WHO) Covid-19 Vaccine Emergency Use List, including China's Sinopharm and Sinovac vaccines and India's Covaxin, from November 22. Travelers who have been fully vaccinated with the vaccines on the list do not need to be quarantined when they arrive in the UK.

2021.11.05

11:06

China's Sinovac says its COVID-19 vaccine is safe for healthy people aged 3-17 years

Asian Tech Press (Nov 5) -- Chinese pharmaceutical company Sinovac Biotech Ltd (SVA: NASDAQ GS) said in a release Friday that its COVID-19 vaccine has a good safety profile in healthy people aged 3-17 years in various ethnic groups.

2021.11.01

08:55

Indonesia approves China's Sinovac COVID-19 vaccine for kids aged 6-11 years

Asian Tech Press (Nov 1) -- Indonesia has approved China's Sinovac COVID-19 vaccine for use in children aged 6-11 years.

2021.10.01

13:40

Australia announces China's Sinovac vaccine as a 'recognised vaccine'

Asian Tech Press (Oct 1) -- Australia's drug regulator announced Friday that China's Sinovac vaccine is a "recognised vaccine".

2021.09.27

08:03

Malaysia study: China's Sinovac vaccine highly effective against serious illness

Asian Tech Press (Sep 27) -- A large real world study in Malaysia shows that China's Sinovac COVID-19 vaccine is also highly effective against serious illness, although vaccines from Pfizer/BioNTech and AstraZeneca have shown better protection efficiency, Reuters reported last Friday.

2021.08.06

07:59

Sinovac to file for EUA for its COVID-19 vaccine against Delta variant in countries

Asian Tech Press -- Yin Weidong, chairman and CEO of Sinovac Biotech Ltd (SVA: NASDAQ GS), said in a speech at the first International Forum on Vaccine Cooperation on August 5, that Sinovac will soon submit applications to national drug regulatory authorities in several countries for clinical studies and Emergency Use Authorization (EUA) of its COVID-19 vaccines against Gamma and Delta variants.

2021.08.05

08:41

China's Sinovac effective against Gamma variant, Brazil study says

The Butantan Institute, a leading medical research institute in Brazil, recently released the results of a study showing that the Chinese Sinovac Covid-19 vaccine can help protect people over 70 years of age effectively against the Gamma Covid-19 variant.

2021.08.04

04:31

Sinovac's COVID-19 vaccine was 58.5% effective, Chilean health authorities say

SANTIAGO, Aug 3 (Reuters) - Sinovac's COVID-19 vaccine was 58.5% effective in preventing symptomatic illness among millions of Chileans who received it between February and July, the Chilean health authorities said on Tuesday, while Pfizer's COVID-19 shot was 87.7% effective and AstraZeneca's was 68.7% effective.

2021.06.29

12:00

Indonesia approves China's Sinovac shot for ages 12 to 17

(Asian Tech Press) Indonesia has approved China's Sinovac shot for ages 12 to 17, according to Indonesian media reports.

2021.06.23

04:04

HKU: 'substantial' antibody-level difference between BioNTech, Sinovac jab recipients

(Asian Tech Press) A Hong Kong research has found that people who received BioNTech's jab had “substantially higher” levels of antibodies than those who vaccinated with China-made Sinovac vaccine, according to the South China Morning Post.

2021.06.07

13:00

China's Sinovac gets nod for over 3 years old in Thailand

China’s Sinovac vaccine has been approved by Thailand for COVID-19 jabs for people over 3 years old.

2021.05.27

04:24

WHO may delay emergency use approval for China's Sinovac vaccine

According to The Wall Street Journal, WHO may delay emergency use approval for China's Sinovac vaccine.

Email Subscription

Newsletters and emails are now available! Delivered on time, every weekday, to keep you up to date with North American business news.

Weekly Highlights

                                    Tesla's (TSLA.O) shares fell as much as 5% in pre-market trading after its fourth-quarter deliveries fell short of expectations.
                            2025-01-02

                                    Tesla (TSLA.O) produced 22,727 other models in the fourth quarter, compared with market forecasts of 22,790.
                            2025-01-02

                                    Yunding Technology: The company currently has no self-owned AI hardware products for sale
                            2025-01-02

                                    Tesla (TSLA.O) Model 3/Y production in the fourth quarter of 2024 was 436,718 units.
                            2025-01-02

                                    Tesla (TSLA.O) shares fell 2.7% in pre-market trading.
                            2025-01-02